Zilia is a Canadian medical technology company commercializing the first clinically available platform for ocular oximetry. Its flagship product, the Zilia Ocular®, measures retinal tissue oxygen saturation (StO₂), providing clinicians with functional insights into retinal metabolism. Through this new generation of functional retinal imaging, Zilia is helping expand the role of metabolic biomarkers in eye care to support earlier detection, more personalized care, and better visual outcomes.